Clinical trial
ARtificial Intelligence for Gross Tumour vOlume Segmentation
NCT05775068 is registered in ClinicalTrials.gov with Maastricht Radiation Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ARtificial Intelligence for Gross Tumour vOlume Segmentation
- Lead sponsor
- Maastricht Radiation Oncology
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 1, 2021
- Completion date
- December 1, 2024
- Enrollment
- 2,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer